Egfr drugs

EGFR targeted therapy is another name for EGFR therapy. This term refers to the fact that these drugs specifically target and bind to the EGFR protein.

Examples of EGFR therapy drugs include afatinib, dacomitinib, erlotinib, gefitinib, and osimertinib. What is target EGFR? EGFR targeted therapy is another name

Drug Classes Antineoplastics; EGFR Inhibitors. EGFR inhibitors. Other names: anti-EGFR, epidermal growth factor receptor inhibitors, erbB-1, HER-1. What are

Osimertinib (Tagrisso) is a drug that targets cells with the T790M mutation. The side effects of this drug are similar to those of other EGFR inhibitors. EGFR

Since the approval of the first EGFR-TKI in 2024, a huge number of EGFR inhibitors were reported. These drugs have broad-spectrum

EGFR gene. Although drugs that inhibit EGFR activity are effective in preventing recurrence in NSCLC patients after tumor resection, these

An oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations. Drugs Drug Targets. Drug, Target

Drugs called EGFR inhibitors can block the signal from EGFR that tells the cancer cells to grow. These drugs are often used to treat

The EGFR tyrosine kinase inhibitor ( TKI ) osimertinib ( Tagrisso ) is the standard drug for the treatment of EGFR-mutated NSCLC, and alectinib